Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine: rule of thumb in prediction studies
Crossref DOI link: https://doi.org/10.1007/s10549-014-3173-6
Published Online: 2014-10-25
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sabour, Siamak
Text and Data Mining valid from 2014-10-25